🔗 Permalink

Inventor profile of:

Daisuke OKAJIMA

City:

Tokyo

Country:

Japan

Published Applications:

Last publication date:

2025-09-18

Top Assignees for applications by Daisuke OKAJIMA

The entities that hold a legal rights for patent applications filed by inventor OKAJIMA Daisuke:

DAIICHI SANKYO COMPANY, LIMITED 21 Tokyo, Japan
SAPPORO MEDICAL UNIVERSITY 3 Sapporo-shi, Hokkaido, Japan
SAPPORO MEDICAL UNIVERSITY 3 Sapporo-shi, Japan
KAZUSA DNA RESEARCH INSTITUTE FOUNDATION 3 CHIBA, Japan
AstraZeneca UK Limited 1 Cambridge, United Kingdom
KAZUSA DNA RESEARCH INSTITUTE FOUNDATION 1 Kisarazu-shi, Japan
SAPPRORO MEDICAL UNIVERSITY 1 Sapporo-shi, Japan
DAIICHI PHARMACEUTICAL CO., LTD. 1 Tokyo, Japan
Sapporo Medical University 1 Sapporo, Japan

Recent patent applications by OKAJIMA Daisuke

Daisuke OKAJIMA from Tokyo, JP has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-18

US20250288687A1

Human necessities

COMBINATION OF ANTIBODY-DRUG CONJUGATES AND DNMT INHIBITORS

#2 | 2025-08-14

US20250257146A1

Chemistry; metallurgy

ANTI-TROP2 ANTIBODY-DRUG CONJUGATE

#3 | 2025-04-10

US20250114647A1

Human necessities

ANTIBODY-DRUG CONJUGATES COMPRISING SUBSTITUTED BENZO[e]PYRROLO[1,2-a][1,4]DIAZEPINES

#4 | 2024-09-12

US20240299573A1

Human necessities

ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE

#5 | 2023-08-31

US20230270870A1

Human necessities

DOSAGE OF AN ANTIBODY-DRUG CONJUGATE

#6 | 2023-03-16

US20230084707A1

Human necessities

ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE

#7 | 2022-12-15

US20220395579A1

Human necessities

Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines

#8 | 2022-04-28

US20220125943A1

Human necessities

Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumor

#9 | 2022-02-10

US20220040324A1

Human necessities

COMBINATION OF ANTIBODY-DRUG CONJUGATE AND KINASE INHIBITOR

#10 | 2022-01-27

US20220023436A1

Human necessities

COMBINATION OF ANTIBODY-DRUG CONJUGATE WITH PARP INHIBITOR

#11 | 2021-12-16

US20210386865A1

Human necessities

METHOD FOR SELECTIVELY MANUFACTURING ANTIBODY-DRUG CONJUGATE

#12 | 2021-11-04

US20210340628A1

Chemistry; metallurgy

Sensitivity marker for antibody-drug conjugate

#13 | 2021-08-05

US20210238303A1

Chemistry; metallurgy

ANTI-TROP2 ANTIBODY-DRUG CONJUGATE

#14 | 2020-08-20

US20200261594A1

Human necessities

Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepines

#15 | 2019-05-16

US20190144559A1

Chemistry; metallurgy

Anti-TROP2 antibody-drug conjugate

#16 | 2018-05-31

US20180147292A1

Human necessities

Method for selectively manufacturing antibody-drug conjugate

#17 | 2018-04-05

US20180094073A1

Chemistry; metallurgy

Anti-TROP2 antibody-drug conjugate

#18 | 2016-10-13

US20160297890A1

Chemistry; metallurgy

Anti-TROP2 antibody-drug conjugate

#19 | 2011-09-15

US20110223175A1

Physics

Gene Encoding G-Protein Coupled Receptor And Gene Product Thereof

#20 | 2010-02-04

US20100029702A1

Chemistry; metallurgy

Method For Identification of Compound Having Anti-Anxiety Effect

#21 | 2009-08-13

US20090203073A1

Physics

DNA encoding a CCK-8S G-protein coupled receptor, and vectors, transformants, cell kits, and methods employing such DNA

#22 | 2006-10-19

US20060234305A1

Physics

Assay employing a g-protein coupled receptor that is activated by CCK-8S

InventorID:

1678296 ⎘